Organovo Holdings Current Ratio 2011-2021 | ONVO

Organovo Holdings current ratio from 2011 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Organovo Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.04B $0.00B 38.03
2021-03-31 $0.04B $0.00B 53.26
2020-12-31 $0.02B $0.00B 24.25
2020-09-30 $0.02B $0.00B 29.61
2020-06-30 $0.03B $0.00B 30.54
2020-03-31 $0.03B $0.00B 15.65
2019-12-31 $0.03B $0.00B 13.19
2019-09-30 $0.03B $0.00B 10.48
2019-06-30 $0.04B $0.00B 10.56
2019-03-31 $0.04B $0.00B 10.32
2018-12-31 $0.04B $0.00B 10.99
2018-09-30 $0.04B $0.00B 12.19
2018-06-30 $0.04B $0.00B 13.18
2018-03-31 $0.05B $0.01B 10.04
2017-12-31 $0.05B $0.00B 11.70
2017-09-30 $0.05B $0.00B 12.93
2017-06-30 $0.06B $0.00B 15.69
2017-03-31 $0.07B $0.01B 10.83
2016-12-31 $0.07B $0.00B 16.20
2016-09-30 $0.05B $0.00B 12.72
2016-06-30 $0.06B $0.00B 17.60
2016-03-31 $0.06B $0.00B 14.18
2015-12-31 $0.07B $0.01B 12.87
2015-09-30 $0.08B $0.01B 14.10
2015-06-30 $0.09B $0.01B 16.65
2015-03-31 $0.05B $0.01B 10.77
2014-12-31 $0.05B $0.00B 13.58
2014-09-30 $0.06B $0.00B 17.71
2014-06-30 $0.05B $0.00B 14.83
2014-03-31 $0.05B $0.00B 25.97
2013-12-31 $0.05B $0.00B 17.42
2013-09-30 $0.05B $0.00B 18.28
2013-06-30 $0.01B $0.01B 1.75
2013-03-31 $0.02B $0.01B 1.93
2012-12-31 $0.00B 0.00
2012-09-30 $0.01B $0.00B 8.43
2012-06-30 $0.01B $0.00B 10.35
2012-03-31 $0.01B $0.00B 9.75
2011-12-31 $0.00B $0.00B 0.52
2011-09-30 $0.00B $0.00B 0.11
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B $0.00B 34.20
2010-09-30 $0.00B 0.00
2010-06-30 $0.00B $0.00B 19.15
2010-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.002B
Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76